Downloads

  1. Robust, High-Throughput Automated Solution For Water Endotoxin Testing 4/21/2026

    High-throughput water endotoxin testing doesn’t have to sacrifice consistency. Gain insight into how an automated workflow delivers reliable results, low variability, and strong control recovery.

  2. Integrated T Cell Activation: Soluble DynActivator CD3/CD28 Prototype 4/21/2026

    Bead-free T cell activation is now achievable with a soluble, GMP-compliant format that supports up to 1.5 billion cells per vial, decouples activation from isolation, and removes with a simple cell wash.

  3. Dynabeads CD3 Depletion Prototype Supporting Solutions From Development To Delivery 4/21/2026

    Residual CD3+ cells shouldn't be the bottleneck in your allogeneic therapy workflow. This prototype achieves <0.5% residual T cells at commercial-scale processing capacity.

  4. Unlocking The Next Wave Of Cancer Vaccines 4/21/2026

    Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.

  5. Anticoagulant Selection Influences T Cell Purity And Yield In Whole Blood Isolation 4/21/2026

    Lithium heparin reduces T cell purity to below 50% and spikes CD15+ contamination in whole blood workflows. See which anticoagulants consistently deliver above 90% CD3+ purity.

  6. Are Lab Blind Spots Slowing Your Down? 4/21/2026

    Overcome data silos and operational blind spots. Explore how a unified digital platform integrates equipment, samples, and workflows to boost efficiency and ensure lab-wide visibility.

  7. Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO 4/21/2026

    Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape.

  8. De-Risk Nucleic Acid Therapeutics Through Strategic Outsourcing 4/20/2026

    Bringing a nucleic acid therapy to market requires specialized formulation and development knowledge. Innovators need rigorous analytical and formulation strategies to achieve stability and quality.

  9. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

    See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

  10. An Integrated, Verified PFS System For Vaccines 4/20/2026

    A pre-verified delivery platform eliminates redundant testing, simplifies regulatory submissions, and optimizes inventory management, allowing teams to focus on drug-specific performance.